These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24377504)

  • 21. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
    Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Prognostic Impact of the Number of Metastatic Lymph Nodes and a New Prognostic Scoring System for Recurrence in Early-Stage Cervical Cancer with High Risk Factors: A Multicenter Cohort Study (KROG 15-04).
    Kwon J; Eom KY; Kim YS; Park W; Chun M; Lee J; Kim YB; Yoon WS; Kim JH; Choi JH; Chang SK; Jeong BK; Lee SH; Cha J
    Cancer Res Treat; 2018 Jul; 50(3):964-974. PubMed ID: 29081219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
    Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Twist enhances risk of poor oncologic outcome in patients with stage Ib to II cervical carcinoma with lymphovascular space involvement.
    Kajiyama H; Shibata K; Umezu T; Mizuno M; Suzuki S; Yamamoto E; Fujiwara S; Kikkawa F
    Hum Pathol; 2013 Feb; 44(2):181-8. PubMed ID: 22974479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic Factors of Cervical Adenocarcinoma Stages IB to IIB.
    Mabuchi Y; Yahata T; Kobayashi A; Tanizaki Y; Shiro M; Ota N; Yagi S; Minami S; Ino K
    Int J Gynecol Cancer; 2015 Nov; 25(9):1677-82. PubMed ID: 26495760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoral lymphatic vessel density and clinicopathologic features of patients with early-stage cervical cancer after radical hysterectomy.
    Zaganelli FL; Carvalho FM; Almeida BG; Bacchi CE; Goes JC; Calil MA; Baracat EC; Carvalho JP
    Int J Gynecol Cancer; 2010 Oct; 20(7):1225-31. PubMed ID: 21135594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 expression in squamous cell carcinoma of the uterine cervix is associated with lymph node metastasis.
    Khunamornpong S; Settakorn J; Sukpan K; Srisomboon J; Ruangvejvorachai P; Thorner PS; Siriaunkgul S
    Gynecol Oncol; 2009 Jan; 112(1):241-7. PubMed ID: 18977022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.
    Kristensen GB; Abeler VM; Risberg B; Trop C; Bryne M
    Gynecol Oncol; 1999 Aug; 74(2):245-51. PubMed ID: 10419739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of peritumoral lymphatic vessel density and lymphatic vessel invasion detected by D2-40 immunostaining in FIGO Ib1-IIa squamous cell cervical cancer.
    Xiong Y; Cao LP; Rao HL; Cai MY; Liang LZ; Liu JH
    Cell Tissue Res; 2012 Jun; 348(3):515-22. PubMed ID: 22492093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
    Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
    Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
    Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
    Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
    Li X; Xu C; Yu Y; Guo Y; Sun H
    BMC Cancer; 2021 Jul; 21(1):866. PubMed ID: 34320931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.
    Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC
    Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
    Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
    PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-free distance from outermost layer of cervix is of prognostic value in surgically treated cervical cancer patients: a multicenter study.
    Saatli B; Olgan S; Gorken IB; Uslu T; Saygili U; Dicle N; Cingillioglu B; Gumurdulu D; Guzel AB; Koyuncuoglu M
    Arch Gynecol Obstet; 2014 Jun; 289(6):1331-5. PubMed ID: 24435497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q; Liu S; Liu H; Zhang J; Guo S; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.